# A Multicenter, Prospective, Non-interventional Cohort Study to Evaluate the Safety and Treatment Pattern of Sodium Zirconium Cyclosilicate for Hyperkalaemia Management in Real World Practice in China

> **NCT05271266** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 1000 (actual)

## Conditions studied

- Hyperkalaemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05271266
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-22
- **Primary completion:** 2023-12-06
- **Final completion:** 2023-12-06
- **Target enrollment:** 1000 (ACTUAL)
- **Last updated:** 2024-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05271266

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05271266, "A Multicenter, Prospective, Non-interventional Cohort Study to Evaluate the Safety and Treatment Pattern of Sodium Zirconium Cyclosilicate for Hyperkalaemia Management in Real World Practice in China". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT05271266. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*